Owners, management and financials
CVR: 42715646
DKK -114,117,791
Gross profit
Net result: DKK -136,526,045
Novo Holdings A/S (33,33-49,99%), Forbion Ventures Fund VI Coöperatief U.A. (33,33-49,99%)
1 more
CVR · view owners
Joanne Smith-Farrell
Board: Goran Mikael Dolsten (chair) and 5 members
CVR · view management
Active
Founded 28 September 2021
CVR · view overview
33 employees
CVR · 2026
Director role ended: Morten Døssing
CVR · 14/10/2026
View the full event history
Orbis Medicines ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Joanne Smith-Farrell. The board consists of Goran Mikael Dolsten (chair), Alonso Ricardo Rodriguez, Edward Timothy Mathers and Joanne Smith-Farrell. The company is owned by Novo Holdings A/S, Forbion Ventures Fund VI Coöperatief U.A. and GF 2022 Global VC S.á r.l.. The company has 33 employees (2026). In 2025, the company reported a gross profit of DKK -114,117,791 and a net result of DKK -136,526,045 compared with DKK -37,020,933 the year before. Equity in the 2025 report amounted to DKK 287,462,567.
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -114.1M | -136.5M | 303.8M | 287.5M | 17 | |
| 202401/01/2024 – 31/12/2024 | -51.6M | -37M | 158.6M | 127M | 1 | |
| 202301/01/2023 – 31/12/2023 | -25.6M | -17.6M | 70.4M | 68.9M | 0 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Orbis Medicines ApS is 42715646.
Orbis Medicines ApS is owned by Novo Holdings A/S, Forbion Ventures Fund VI Coöperatief U.A. and GF 2022 Global VC S.á r.l..
The management of Orbis Medicines ApS consists of Joanne Smith-Farrell.
The board of Orbis Medicines ApS consists of Goran Mikael Dolsten, Alonso Ricardo Rodriguez and Edward Timothy Mathers, with Goran Mikael Dolsten as chair.
In 2025, Orbis Medicines ApS reported a gross profit of DKK -114,117,791.
Orbis Medicines ApS had 33 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of October 14, 2026, Joanne Smith-Farrell has joined the board of directors of Orbis Medicines ApS.
As of October 14, 2026, Morten Døssing has left the board of directors of Orbis Medicines ApS.
As of October 14, 2026, Joanne Smith-Farrell is registered as adm. dir. of Orbis Medicines ApS.
As of October 14, 2026, Morten Døssing has stepped down as adm. dir. of Orbis Medicines ApS.
Orbis Medicines ApS has published its annual report for 2025. Gross profit came to DKK -114,117,791, and the net result was DKK -136,526,045.
Orbis Medicines ApS has published its annual report for 2024. Gross profit came to DKK -51,629,104, and the net result was DKK -37,020,933.
As of March 1, 2025, Marco Boorsma has joined the board of directors of Orbis Medicines ApS.
As of March 1, 2025, Goran Mikael Dolsten has joined the board of directors of Orbis Medicines ApS.
As of February 28, 2025, Marco Boorsma has left the board of directors of Orbis Medicines ApS.
As of February 1, 2025, Morten Døssing is registered as adm. dir. of Orbis Medicines ApS.
As of February 1, 2025, Søren Sylvester Skjærbæk has stepped down as director of Orbis Medicines ApS.
As of December 27, 2024, Søren Møller has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Morten Døssing has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Marco Boorsma has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Edward Timothy Mathers has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Christian Heinis has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, João Carlos Ribas de Almeida has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Vanessa Carle has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Novo Holdings A/S is registered as an owner of Orbis Medicines ApS with an ownership share of 33%.
As of December 27, 2024, is registered as an owner of Orbis Medicines ApS with an ownership share of 10%.
As of December 26, 2024, Morten Døssing has left the board of directors of Orbis Medicines ApS.
As of December 26, 2024, Marco Boorsma has left the board of directors of Orbis Medicines ApS.
As of December 10, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of Orbis Medicines ApS.
As of December 10, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Orbis Medicines ApS.
As of November 1, 2024, Alonso Ricardo Rodriguez has joined the board of directors of Orbis Medicines ApS.
As of October 23, 2024, João Carlos Ribas de Almeida has stepped down as director of Orbis Medicines ApS.
Orbis Medicines ApS has published its annual report for 2023. Gross profit came to DKK -25,595,747, and the net result was DKK -17,637,755.
As of February 2, 2024, Vanessa Carle has joined the board of directors of Orbis Medicines ApS.
As of February 2, 2024, Marco Boorsma has joined the board of directors of Orbis Medicines ApS.
As of February 2, 2024, is registered as an owner of Orbis Medicines ApS with an ownership share of 33%.
Orbis Medicines ApS has published its interim report for the period September 28, 2021 to December 31, 2022.
As of September 28, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Orbis Medicines ApS.
As of September 28, 2021, Morten Døssing has joined the board of directors of Orbis Medicines ApS.
As of September 28, 2021, Christian Heinis has joined the board of directors of Orbis Medicines ApS.
As of September 28, 2021, João Carlos Ribas de Almeida has joined the board of directors of Orbis Medicines ApS.
As of September 28, 2021, Søren Sylvester Skjærbæk is registered as director of Orbis Medicines ApS.
As of September 28, 2021, João Carlos Ribas de Almeida is registered as director of Orbis Medicines ApS.
Orbis Medicines ApS was founded on September 28, 2021.
3 news items and press releases
Sources: Via Ritzau and Danish news media. Links open at the source.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
